Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance

Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance

Patients undergoing immunotherapy always exhibit a low-response rate due to tumor heterogeneity and immune surveillance in the tumor. Angiogenesis plays an important role in affecting the status of tumor-infiltrated lymphocytes by inducing hypoxia and acidosis microenvironment, suggesting its synerg...

Full description

Bibliographic Details
Main Authors: Fasheng Li, Xinmei Shao, Dehui Liu, Xiaogang Jiao, Xinqi Yang, Wencai Yang, Xiaoyan Liu
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceutics
Subjects:
anti-angiogenesis therapy
vascular disruption
immunogenic cell death
immune surveillance
Online Access:https://www.mdpi.com/1999-4923/14/9/1809

Internet

https://www.mdpi.com/1999-4923/14/9/1809

Similar Items